Report Cover

Global mRNA Vaccines & Therapeutics Market Growth 2021-2026


According to this latest study, the 2021 growth of mRNA Vaccines & Therapeutics will have significant change from previous year. By the most conservative estimates of global mRNA Vaccines & Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of  % in 2021, from US$  million in 2020. Over the next five years the mRNA Vaccines & Therapeutics market will register a -48.1% CAGR in terms of revenue, the global market size will reach US$  million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
    Infectious Disease Vaccines
    Cancer Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
    Infectious Disease
    Cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
    Moderna Therapeutics
    CureVac
    Translate Bio
    BioNTech
    Sangamo Therapeutics
    Argos Therapeutics
    In-Cell-Art
    eTheRNA
    Ethris
    Tiba Biotechnology
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global mRNA Vaccines & Therapeutics Consumption 2016-2026
        2.1.2 mRNA Vaccines & Therapeutics Consumption CAGR by Region
    2.2 mRNA Vaccines & Therapeutics Segment by Type
        2.2.1 Infectious Disease Vaccines
        2.2.2 Cancer Vaccines
    2.3 mRNA Vaccines & Therapeutics Sales by Type
        2.3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)
        2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2016-2021)
        2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2016-2021)
    2.4 mRNA Vaccines & Therapeutics Segment by Application
        2.4.1 Infectious Disease
        2.4.2 Cancer
    2.5 mRNA Vaccines & Therapeutics Sales by Application
        2.5.1 Global mRNA Vaccines & Therapeutics Sale Market Share by Application (2016-2021)
        2.5.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Application (2016-2021)
        2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Application (2016-2021)

3 Global mRNA Vaccines & Therapeutics by Company
    3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Company
        3.1.1 Global mRNA Vaccines & Therapeutics Sales by Company (2019-2021)
        3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2019-2021)
    3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company
        3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Company (2019-2021)
        3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2019-2021)
    3.3 Global mRNA Vaccines & Therapeutics Sale Price by Company
    3.4 Global Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers mRNA Vaccines & Therapeutics Product Location Distribution
        3.4.2 Players mRNA Vaccines & Therapeutics Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 mRNA Vaccines & Therapeutics by Region
    4.1 Global mRNA Vaccines & Therapeutics by Region
        4.1.1 Global mRNA Vaccines & Therapeutics Sales by Region
        4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Region
    4.2 Americas mRNA Vaccines & Therapeutics Sales Growth
    4.3 APAC mRNA Vaccines & Therapeutics Sales Growth
    4.4 Europe mRNA Vaccines & Therapeutics Sales Growth
    4.5 Middle East & Africa mRNA Vaccines & Therapeutics Sales Growth

5 Americas
    5.1 Americas mRNA Vaccines & Therapeutics Sales by Country
        5.1.1 Americas mRNA Vaccines & Therapeutics Sales by Country (2016-2021)
        5.1.2 Americas mRNA Vaccines & Therapeutics Revenue by Country (2016-2021)
    5.2 Americas mRNA Vaccines & Therapeutics Sales by Type
    5.3 Americas mRNA Vaccines & Therapeutics Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC mRNA Vaccines & Therapeutics Sales by Region
        6.1.1 APAC mRNA Vaccines & Therapeutics Sales by Region (2016-2021)
        6.1.2 APAC mRNA Vaccines & Therapeutics Revenue by Region (2016-2021)
    6.2 APAC mRNA Vaccines & Therapeutics Sales by Type
    6.3 APAC mRNA Vaccines & Therapeutics Sales by Application
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe mRNA Vaccines & Therapeutics by Country
        7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2016-2021)
        7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2021)
    7.2 Europe mRNA Vaccines & Therapeutics Sales by Type
    7.3 Europe mRNA Vaccines & Therapeutics Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Country
        8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2021)
        8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2021)
    8.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type
    8.3 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Country

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Marketing, Distributors and Customer
    10.1 Sales Channel
        10.1.1 Direct Channels
        10.1.2 Indirect Channels
    10.2 mRNA Vaccines & Therapeutics Distributors
    10.3 mRNA Vaccines & Therapeutics Customer

11 Global mRNA Vaccines & Therapeutics Market Forecast
    11.1 Global mRNA Vaccines & Therapeutics Forecast by Region
        11.1.1 Global mRNA Vaccines & Therapeutics Forecast by Regions (2021-2026)
        11.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Regions (2021-2026)
    11.2 Americas Forecast by Country
    11.3 APAC Forecast by Region
    11.4 Europe Forecast by Country
    11.5 Middle East & Africa Forecast by Country
    11.6 Global mRNA Vaccines & Therapeutics Forecast by Type
    11.7 Global mRNA Vaccines & Therapeutics Forecast by Application

12 Key Players Analysis
    12.1 Moderna Therapeutics
        12.1.1 Moderna Therapeutics Company Information
        12.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered
        12.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
        12.1.4 Moderna Therapeutics Main Business Overview
        12.1.5 Moderna Therapeutics Latest Developments
    12.2 CureVac
        12.2.1 CureVac Company Information
        12.2.2 CureVac mRNA Vaccines & Therapeutics Product Offered
        12.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
        12.2.4 CureVac Main Business Overview
        12.2.5 CureVac Latest Developments
    12.3 Translate Bio
        12.3.1 Translate Bio Company Information
        12.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Offered
        12.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
        12.3.4 Translate Bio Main Business Overview
        12.3.5 Translate Bio Latest Developments
    12.4 BioNTech
        12.4.1 BioNTech Company Information
        12.4.2 BioNTech mRNA Vaccines & Therapeutics Product Offered
        12.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
        12.4.4 BioNTech Main Business Overview
        12.4.5 BioNTech Latest Developments
    12.5 Sangamo Therapeutics
        12.5.1 Sangamo Therapeutics Company Information
        12.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered
        12.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
        12.5.4 Sangamo Therapeutics Main Business Overview
        12.5.5 Sangamo Therapeutics Latest Developments
    12.6 Argos Therapeutics
        12.6.1 Argos Therapeutics Company Information
        12.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered
        12.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
        12.6.4 Argos Therapeutics Main Business Overview
        12.6.5 Argos Therapeutics Latest Developments
    12.7 In-Cell-Art
        12.7.1 In-Cell-Art Company Information
        12.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Offered
        12.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
        12.7.4 In-Cell-Art Main Business Overview
        12.7.5 In-Cell-Art Latest Developments
    12.8 eTheRNA
        12.8.1 eTheRNA Company Information
        12.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Offered
        12.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
        12.8.4 eTheRNA Main Business Overview
        12.8.5 eTheRNA Latest Developments
    12.9 Ethris
        12.9.1 Ethris Company Information
        12.9.2 Ethris mRNA Vaccines & Therapeutics Product Offered
        12.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
        12.9.4 Ethris Main Business Overview
        12.9.5 Ethris Latest Developments
    12.10 Tiba Biotechnology
        12.10.1 Tiba Biotechnology Company Information
        12.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered
        12.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
        12.10.4 Tiba Biotechnology Main Business Overview
        12.10.5 Tiba Biotechnology Latest Developments

13 Research Findings and Conclusion

List of Tables Table 1. mRNA Vaccines & Therapeutics Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Infectious Disease Vaccines Table 3. Major Players of Cancer Vaccines Table 4. Global mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses) Table 5. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021) Table 6. Global mRNA Vaccines & Therapeutics Revenue by Type (2016-2021) & ($ million) Table 7. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2021) Table 8. Global mRNA Vaccines & Therapeutics Sale Price by Type (2016-2021) Table 9. Global mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses) Table 10. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Table 11. Global mRNA Vaccines & Therapeutics Value by Application (2016-2021) Table 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2016-2021) Table 13. Global mRNA Vaccines & Therapeutics Sale Price by Application (2016-2021) Table 14. Global mRNA Vaccines & Therapeutics Sales by Company (2019-2021) & (M Doses) Table 15. Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2019-2021) Table 16. Global mRNA Vaccines & Therapeutics Revenue by Company (2019-2021) ($ Millions) Table 17. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2019-2021) Table 18. Global mRNA Vaccines & Therapeutics Sale Price by Company (2019-2021) Table 19. Key Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution and Sales Area Table 20. Players mRNA Vaccines & Therapeutics Products Offered Table 21. mRNA Vaccines & Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global mRNA Vaccines & Therapeutics Sales by Region (2016-2021) (M Doses) Table 25. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021) Table 26. Global mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & ($ Millions) Table 27. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2021) Table 28. Americas mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses) Table 29. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021) Table 30. Americas mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021) Table 32. Americas mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses) Table 33. Americas mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021) Table 34. Americas mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses) Table 35. Americas mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Table 36. APAC mRNA Vaccines & Therapeutics Sales by Region (2016-2021) & (M Doses) Table 37. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021) Table 38. APAC mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2021) Table 40. APAC mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses) Table 41. APAC mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021) Table 42. APAC mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses) Table 43. APAC mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Table 44. Europe mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses) Table 45. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021) Table 46. Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021) Table 48. Europe mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses) Table 49. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021) Table 50. Europe mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses) Table 51. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses) Table 53. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses) Table 57. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses) Table 59. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of mRNA Vaccines & Therapeutics Table 61. Key Application and Potential Industries of mRNA Vaccines & Therapeutics Table 62. Key Challenges of mRNA Vaccines & Therapeutics Table 63. Key Trends of mRNA Vaccines & Therapeutics Table 64. mRNA Vaccines & Therapeutics Distributors List Table 65. mRNA Vaccines & Therapeutics Customer List Table 66. Global mRNA Vaccines & Therapeutics Sales Forecast by Region (2021-2026) & (M Doses) Table 67. Global mRNA Vaccines & Therapeutics Consumption Market Forecast by Region Table 68. Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas mRNA Vaccines & Therapeutics Sales Forecast by Country (2021-2026) & (M Doses) Table 71. Americas mRNA Vaccines & Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC mRNA Vaccines & Therapeutics Sales Forecast by Region (2021-2026) & (M Doses) Table 73. APAC mRNA Vaccines & Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe mRNA Vaccines & Therapeutics Sales Forecast by Country (2021-2026) & (M Doses) Table 75. Europe mRNA Vaccines & Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa mRNA Vaccines & Therapeutics Sales Forecast by Country (2021-2026) & (M Doses) Table 77. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2021-2026) & (M Doses) Table 79. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2021-2026) Table 80. Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Type (2021-2026) Table 82. Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2021-2026) & (M Doses) Table 83. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2021-2026) Table 84. Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Application (2021-2026) Table 86. Moderna Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 87. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered Table 88. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 89. Moderna Therapeutics Main Business Table 90. Moderna Therapeutics Latest Developments Table 91. CureVac Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 92. CureVac mRNA Vaccines & Therapeutics Product Offered Table 93. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 94. CureVac Main Business Table 95. CureVac Latest Developments Table 96. Translate Bio Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 97. Translate Bio mRNA Vaccines & Therapeutics Product Offered Table 98. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 99. Translate Bio Main Business Table 100. Translate Bio Latest Developments Table 101. BioNTech Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 102. BioNTech mRNA Vaccines & Therapeutics Product Offered Table 103. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 104. BioNTech Main Business Table 105. BioNTech Latest Developments Table 106. Sangamo Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 107. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered Table 108. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 109. Sangamo Therapeutics Main Business Table 110. Sangamo Therapeutics Latest Developments Table 111. Argos Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 112. Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered Table 113. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 114. Argos Therapeutics Main Business Table 115. Argos Therapeutics Latest Developments Table 116. In-Cell-Art Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 117. In-Cell-Art mRNA Vaccines & Therapeutics Product Offered Table 118. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 119. In-Cell-Art Main Business Table 120. In-Cell-Art Latest Developments Table 121. eTheRNA Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 122. eTheRNA mRNA Vaccines & Therapeutics Product Offered Table 123. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 124. eTheRNA Main Business Table 125. eTheRNA Latest Developments Table 126. Ethris Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 127. Ethris mRNA Vaccines & Therapeutics Product Offered Table 128. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 129. Ethris Main Business Table 130. Ethris Latest Developments Table 131. Tiba Biotechnology Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 132. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered Table 133. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E) Table 134. Tiba Biotechnology Main Business Table 135. Tiba Biotechnology Latest Developments List of Figures Figure 1. Picture of mRNA Vaccines & Therapeutics Figure 2. mRNA Vaccines & Therapeutics Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global mRNA Vaccines & Therapeutics Sales Growth Rate 2016-2026 (M Doses) Figure 7. Global mRNA Vaccines & Therapeutics Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. mRNA Vaccines & Therapeutics Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Infectious Disease Vaccines Figure 10. Product Picture of Cancer Vaccines Figure 11. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 Figure 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2021) Figure 13. mRNA Vaccines & Therapeutics Consumed in Infectious Disease Figure 14. Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2016-2021) & (M Doses) Figure 15. mRNA Vaccines & Therapeutics Consumed in Cancer Figure 16. Global mRNA Vaccines & Therapeutics Market: Cancer (2016-2021) & (M Doses) Figure 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021) Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application in 2020 Figure 19. mRNA Vaccines & Therapeutics Revenue Market by Company in 2020 ($ Million) Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company in 2020 Figure 21. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2016-2021) Figure 22. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2020 Figure 23. Americas mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses) Figure 24. Americas mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions) Figure 25. APAC mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses) Figure 26. APAC mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions) Figure 27. Europe mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses) Figure 28. Europe mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses) Figure 30. Middle East & Africa mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions) Figure 31. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020 Figure 32. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020 Figure 33. Americas mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 Figure 34. Americas mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020 Figure 35. United States mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region in 2020 Figure 40. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2020 Figure 41. APAC mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 Figure 42. APAC mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020 Figure 43. China mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 47. India mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020 Figure 50. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020 Figure 51. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 Figure 52. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020 Figure 53. Germany mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 54. France mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 55. UK mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020 Figure 59. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 Figure 61. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020 Figure 62. Egypt mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us